TP53 and colorectal cancer: Liang et al. reported that PDK2 promoted the glycolytic metabolism of colorectal cancer cells, and dichloroacetate elevated the chemosensitivity of colorectal cancer cells via p53/miR-149-3p/PDK2 axis [22].